New patent for Optinose Us drug XHANCE

Annual Drug Patent Expirations for XHANCE Xhance is a drug marketed by Optinose Us Inc and is included in one NDA. There are sixteen patents protecting this drug. XHANCE drug…

The post New patent for Optinose Us drug XHANCE appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Do NOT follow this link or you will be banned from the site!